PIFELTRO 100 MG TABLET

doravirine
$60.9497per EA

Strength

100 mg/1

NDC

00006306901

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/6/2026

Active Ingredients

DORAVIRINE

Approval Type

New Drug (NDA)

FDA Application

NDA210806

On Market Since

7/20/2018

Pharmacological Classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.3%

1Y

+2.7%

3Y

+12.2%

5Y

+25.0%

All

+36.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.